Developer docs
API playgroundTry for free, no card

Search company profiles

NanoTemper Technologies

Full company profile

uuid00085jj

Namestring
NanoTemper Technologies
Legal namestring
NanoTemper Technologies GmbH
Company typeenum
Private
Founded yearint
2008
Descriptiontext

NanoTemper Technologies GmbH, founded in 2008 in Munich by Dr. Stefan Duhr and Dr. Philipp Baaske, develops and sells biophysical characterization instruments that help scientists characterize proteins and molecular interactions during drug discovery and development. The company's portfolio spans proprietary measurement technologies — MicroScale Thermophoresis (MST), nanoDSF, Dynamic and Static Light Scattering (DLS/SLS), Backreflection, Spectral Shift, Temperature-Related Intensity Change (TRIC), and (since November 2025) Nanofluidic Scattering Microscopy (NSM) acquired from Envue Technologies. These are commercialized through four core instrument platforms: Prometheus Panta (multi-parameter protein stability), Dianthus and Dianthus uHTS (affinity screening, including high-throughput), Monolith and Monolith Omni (affinity measurement via MST), and Andromeda (crude-lysate protein stability), supported by Tycho for rapid quality checks. End customers are biopharmaceutical companies developing protein therapeutics and biologics, researchers working on Targeted Protein Degradation (TPD) and membrane proteins, contract research organizations, and academic scientists.

NanoTemper generates revenue through four streams: one-time instrument sales (Prometheus Panta, Monolith, Dianthus, Andromeda, Tycho), recurring consumables (proprietary capillary chips, 384-well plates, labeling kits, buffer exploration kits) sold via shop.nanotempertech.com, software licenses, and multi-year service and maintenance contracts. Instruments and software are quote-priced for enterprise buyers, while consumables carry listed online pricing. The company distributes via nine direct regional offices (Munich, South San Francisco, Boston, Toronto, Bangalore, Beijing, Shanghai, Yokohama, Krakow) and a global distributor network covering 15+ additional countries including Japan, South Korea, Australia/NZ, India, China, Brazil, Mexico, South Africa, and Israel. The Japan NanoDSF capillaries segment is a notable scale signal, with NanoTemper holding 60–70% of installed instruments. The company remains privately held and founder-owned, with no disclosed external funding rounds or institutional investors.

Short descriptiontext

NanoTemper Technologies develops biophysical characterization instruments and proprietary consumables for protein stability, affinity, and molecular interaction analysis, serving biopharmaceutical drug discovery teams, contract research organizations, and academic researchers across global markets.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersMunich, Germany
HQ citystring
Munich
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices9 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
biophysical characterization, protein stability instruments, label-free binding assays, molecular interaction analysis, drug discovery tools
Industry3 codes
PRIMARYHLAGADAK
Material Characterization & Spectroscopy (NMR/FTIR/MS)
SECONDARYHLAGAHAI
Solid-State Chemistry & Preformulation (Polymorph/Crystallization)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
SECONDARYHLAGAHAJ
Crystallization, Particle Engineering & Micronization Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
NAICS code2 codes
  • Analytical Laboratory Instrument Manufacturing334516
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing3345
SIC code1 code
  • Laboratory Analytical Instruments3826
Product category
Biophysical Characterization Instruments
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Instruments and Hardware
TypeOne Time License
Description

Sale of biophysical characterization instruments including Prometheus Panta, Monolith, Dianthus, Dianthus uHTS, Andromeda, and Tycho systems.

nanotempertech.com
2Consumables and Reagents
TypeSubscription Recurring
Description

Capillaries, capillary chips, protein labeling kits, buffer exploration kits, control kits, and assay development kits sold through online store.

nanotempertech.com
3Software Licenses
TypeSubscription Recurring
Description

Software solutions for instrument control and data analysis.

nanotempertech.com
4Service and Maintenance
TypeSubscription Recurring
Description

Service contracts and maintenance offerings for instruments.

nanotempertech.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels6 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations, Infrastructure
Pricing details1 tier
1Instruments and software require quote-based pricing
ModelOtherBilling cadenceMulti-year contract
Notes

Pricing not publicly disclosed; requires contacting sales team or distributor network.

nanotempertech.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

NanoTemper Technologies develops and manufactures biophysical characterization instruments, proprietary consumables, and analysis software that enable drug discovery and protein research scientists to measure protein stability, aggregation, and molecular binding interactions. The core product lines — Prometheus Panta, Dianthus / Dianthus uHTS, Monolith / Monolith Omni, Andromeda, and Tycho NT.6 — are supported by labeling kits, capillary chips, and plates sold via the company's online shop and direct sales channels.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • From data to decisions - enabling breakthrough biophysical characterization
Product overview1 text field

NanoTemper Technologies develops a comprehensive portfolio of biophysical characterization instruments and consumables for drug discovery and protein research. The product ecosystem is organized around four core instrument lines: Prometheus Panta for multi-parameter protein stability analysis, Dianthus for affinity screening (including high-throughput Dianthus uHTS), Monolith for affinity measurement using MST technology (including Monolith Omni), and Andromeda for crude lysate analysis. The portfolio also includes Tycho for rapid quality checks. These instruments are supported by a comprehensive range of proprietary labeling kits (RED-NHS, RED-Maleimide, His-Tag, Biotin, Fc-specific), assay development kits, and precision capillary consumables. Key technology platforms include nanoDSF, Dynamic Light Scattering (DLS), Static Light Scattering (SLS), Backreflection, Spectral Shift, MicroScale Thermophoresis (MST), and Temperature-Related Intensity Change (TRIC), enabling measurements from protein stability to molecular interaction analysis. Recent expansion includes the acquisition of Envue Technologies and its Nanofluidic Scattering Microscopy (NSM) technology for single-molecule, label-free analysis.

Product and service17 records
1Prometheus Panta
CategoryBiophysical characterization instrument
Description

Multi-parameter protein stability instrument combining nanoDSF, DLS, SLS, and Backreflection to measure thermal unfolding and colloidal stability of proteins in a single run, used by biopharma and academic researchers for biologics characterization.

2Dianthus
CategoryBiophysical characterization instrument
Description

Affinity screening instrument enabling in-solution binding analysis for tough drug-discovery targets via Spectral Shift technology, supporting confident candidate decisions in targeted protein degradation and biologics programs.

3Dianthus uHTS
CategoryBiophysical characterization instrument
Description

High-throughput screening version of the Dianthus platform designed to accelerate screening and discovery workflows with faster turnaround for affinity measurements.

4Monolith
CategoryBiophysical characterization instrument
Description

Affinity measurement instrument based on MicroScale Thermophoresis (MST), requiring minimal sample while delivering molecular interaction insights for protein research and drug discovery.

5Monolith Omni
CategoryBiophysical characterization instrument
Description

Affinity measurement instrument variant of the Monolith platform offering more answers with less complexity in molecular interaction analysis.

6Andromeda
CategoryBiophysical characterization instrument
Description

Protein stability characterization instrument designed for analysis of crude lysates, enabling early-stage decision-making without purification requirements for biologics and protein research workflows.

7Tycho NT.6
CategoryBiophysical characterization instrument
Description

Rapid protein quality check instrument using capillary-based technology suitable for virtually all buffers and sample concentrations, used as a fast triage tool before deeper characterization.

8Protein Labeling Kit RED-NHS 2nd Generation
CategoryConsumable / Reagent
Description

Amine-reactive NHS-ester labeling kit for affinity studies that delivers higher binding amplitudes and improved signal-to-noise ratios for proteins larger than 5 kDa.

9Protein Labeling Kit RED-MALEIMIDE 2nd Generation
CategoryConsumable / Reagent
Description

Cysteine-reactive labeling kit enabling site-specific labeling and affinity studies with improved data quality for previously challenging targets.

10His-Tag Labeling Kit RED-tris-NTA 2nd Generation
CategoryConsumable / Reagent
Description

Site-specific, purification-free labeling kit for His-tagged proteins and peptides, compatible with both purified and crude samples.

11Andromeda His-Tag Labeling Kit
CategoryConsumable / Reagent
Description

Site-specific labeling kit for polyhistidine-tagged proteins in crude lysate, completing labeling in 30 minutes without dye removal required.

12Biotinylated Target Labeling Kit
CategoryConsumable / Reagent
Description

Site-directed labeling kit for biotin-tagged proteins and peptides with a 15-minute labeling protocol and no dye removal required.

13Human Fc Labeling Kit
CategoryConsumable / Reagent
Description

Site-specific labeling kit for human Fc antibody regions with a purification-free workflow optimized for Spectral Shift technology.

14Buffer Exploration Kit
CategoryConsumable / Reagent
Description

96 deep-well plate containing various buffer conditions for MST, TRIC, protein stability, purification, and storage assay development.

15Monolith NT.Automated Capillary Chips
CategoryConsumable
Description

High-precision glass capillaries for automated Monolith instruments, providing 384 data points per package for high-throughput affinity measurements.

16Prometheus NT.Plex Capillary Chips
CategoryConsumable
Description

nanoDSF-grade capillary chips for use with Prometheus Panta instruments, available in standard and high-sensitivity variants for different protein concentration ranges.

17Dianthus 384-well Plates
CategoryConsumable
Description

Barcoded 384-well plates for TRIC measurements with the Dianthus system, featuring hard-sided black/black construction with clear bottom and 18-25 µL working volume.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-11-05
Description

Acquisition of Swedish startup Envue Technologies specializing in Nanofluidic Scattering Microscopy (NSM). This acquisition enhances NanoTemper's biophysical analysis portfolio and supports early-stage biopharmaceutical research, particularly in nucleic acid and protein therapeutic discovery. Integration of NSM technology with spectral shift analysis expands capabilities.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Broad incumbent with Biacore SPR systems that compete directly with Monolith/Dianthus for affinity and kinetic analysis, plus a large bioprocessing and protein purification portfolio that gives Cytiva significant cross-sell leverage against NanoTemper in biopharma accounts.

TypeBroad incumbent
Description

Broad incumbent in analytical instruments with mass spectrometry and biophysical tools that overlap with NanoTemper's protein characterization workflows in structural biology and biologics development.

TypeDirect peer
Description

Direct competitor in biophysical characterization, offering Zetasizer (DLS), light scattering, and protein characterization tools that overlap directly with NanoTemper's Prometheus and DLS portfolio for biologics development and formulation.

4Wyatt Technology
TypeDirect peer
Description

Closest direct peer in light-scattering-based protein characterization, with DLS/SLS/MALS instruments and microcalorimetry used for the same biologics, formulation, and biophysics workflows that NanoTemper's Prometheus Panta platform addresses.

TypeBroad incumbent
Description

Broad incumbent offering a full analytical and life-sciences instrument stack, including chromatography, mass spectrometry, and protein interaction tools that compete with NanoTemper's biophysical portfolio as part of larger procurement deals.

TypeBroad incumbent
Description

Broad incumbent in analytical instruments and chromatography with growing presence in biologics characterization, competing with NanoTemper at the workflow level for biopharma QC and characterization budgets.

TypeEmerging player
Description

Emerging player in biologics characterization tools (including Uncle for stability and Hunky for stability/aggregation), competing with portions of NanoTemper's Prometheus and Tycho offerings in the biologics formulation and developability workflow.

TypeBroad incumbent
Description

Broad incumbent through FortéBio's BLI (Bio-Layer Interferometry) Octet platform, which competes with MST and TRIC for label-free protein interaction and quantitation, and brings significant scale and bioprocess bundling power.

TypeDirect peer
Description

Direct competitor in label-free affinity measurement, offering the WAVEsystem (a grating-coupled interferometry platform) that competes head-to-head with NanoTemper's Monolith/MST and Dianthus/TRIC instruments for kinetic and affinity analysis.

TypeDirect peer
Description

Direct competitor using switchSENSE technology for real-time kinetic and affinity measurements on DNA nanolevers, overlapping with Monolith/MST and Dianthus use cases in protein interaction and drug discovery characterization.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries7 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

NanoTemper Technologies

Biophysical Characterization Instrumentsnanotempertech.com

NanoTemper Technologies develops biophysical characterization instruments and proprietary consumables for protein stability, affinity, and molecular interaction analysis, serving biopharmaceutical drug discovery teams, contract research organizations, and academic researchers across global markets.

What NanoTemper Technologies does

NanoTemper Technologies GmbH, founded in 2008 in Munich by Dr. Stefan Duhr and Dr. Philipp Baaske, develops and sells biophysical characterization instruments that help scientists characterize proteins and molecular interactions during drug discovery and development. The company's portfolio spans proprietary measurement technologies — MicroScale Thermophoresis (MST), nanoDSF, Dynamic and Static Light Scattering (DLS/SLS), Backreflection, Spectral Shift, Temperature-Related Intensity Change (TRIC), and (since November 2025) Nanofluidic Scattering Microscopy (NSM) acquired from Envue Technologies. These are commercialized through four core instrument platforms: Prometheus Panta (multi-parameter protein stability), Dianthus and Dianthus uHTS (affinity screening, including high-throughput), Monolith and Monolith Omni (affinity measurement via MST), and Andromeda (crude-lysate protein stability), supported by Tycho for rapid quality checks. End customers are biopharmaceutical companies developing protein therapeutics and biologics, researchers working on Targeted Protein Degradation (TPD) and membrane proteins, contract research organizations, and academic scientists.

NanoTemper generates revenue through four streams: one-time instrument sales (Prometheus Panta, Monolith, Dianthus, Andromeda, Tycho), recurring consumables (proprietary capillary chips, 384-well plates, labeling kits, buffer exploration kits) sold via shop.nanotempertech.com, software licenses, and multi-year service and maintenance contracts. Instruments and software are quote-priced for enterprise buyers, while consumables carry listed online pricing. The company distributes via nine direct regional offices (Munich, South San Francisco, Boston, Toronto, Bangalore, Beijing, Shanghai, Yokohama, Krakow) and a global distributor network covering 15+ additional countries including Japan, South Korea, Australia/NZ, India, China, Brazil, Mexico, South Africa, and Israel. The Japan NanoDSF capillaries segment is a notable scale signal, with NanoTemper holding 60–70% of installed instruments. The company remains privately held and founder-owned, with no disclosed external funding rounds or institutional investors.

NanoTemper Technologies firmographics

Firmographics
Name
NanoTemper Technologies
Legal name
NanoTemper Technologies GmbH
Website
https://nanotempertech.com
Company type
Private
Founded year
2008
Operating status
Operating
Headcount range
101–250 employees
Short description
NanoTemper Technologies develops biophysical characterization instruments and proprietary consumables for protein stability, affinity, and molecular interaction analysis, serving biopharmaceutical drug discovery teams, contract research organizations, and academic researchers across global markets.
Ownership category
akta.pro rank

NanoTemper Technologies industry classification

Industry
Product category
Biophysical Characterization Instruments
NAICS
Analytical Laboratory Instrument Manufacturing (334516), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
SIC
Laboratory Analytical Instruments (3826)
akta.pro industry
PRIMARYHLAGADAK
Material Characterization & Spectroscopy (NMR/FTIR/MS)
SECONDARYHLAGAHAI
Solid-State Chemistry & Preformulation (Polymorph/Crystallization)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
SECONDARYHLAGAHAJ
Crystallization, Particle Engineering & Micronization Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services

Keywords

  • Biophysical characterization
  • Protein stability instruments
  • Label-free binding assays
  • Molecular interaction analysis
  • Drug discovery tools

Where NanoTemper Technologies is headquartered

Location

Headquarters

HQ city
Munich
HQ country
Germany
HQ region
Europe

Offices9 records

Markets served

NanoTemper Technologies business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Instruments and Hardware: Sale of biophysical characterization instruments including Prometheus Panta, Monolith, Dianthus, Dianthus uHTS, Andromeda, and Tycho systems.
  2. Consumables and Reagents: Capillaries, capillary chips, protein labeling kits, buffer exploration kits, control kits, and assay development kits sold through online store.
  3. Software Licenses: Software solutions for instrument control and data analysis.
  4. Service and Maintenance: Service contracts and maintenance offerings for instruments.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractInstruments and software require quote-based pricing

Go-to-market motion2 records

Distribution channels6 records

Marketing channels7 records

NanoTemper Technologies product offering

Product offering

Core offering

NanoTemper Technologies develops and manufactures biophysical characterization instruments, proprietary consumables, and analysis software that enable drug discovery and protein research scientists to measure protein stability, aggregation, and molecular binding interactions. The core product lines — Prometheus Panta, Dianthus / Dianthus uHTS, Monolith / Monolith Omni, Andromeda, and Tycho NT.6 — are supported by labeling kits, capillary chips, and plates sold via the company's online shop and direct sales channels.

Product overview

NanoTemper Technologies develops a comprehensive portfolio of biophysical characterization instruments and consumables for drug discovery and protein research. The product ecosystem is organized around four core instrument lines: Prometheus Panta for multi-parameter protein stability analysis, Dianthus for affinity screening (including high-throughput Dianthus uHTS), Monolith for affinity measurement using MST technology (including Monolith Omni), and Andromeda for crude lysate analysis. The portfolio also includes Tycho for rapid quality checks. These instruments are supported by a comprehensive range of proprietary labeling kits (RED-NHS, RED-Maleimide, His-Tag, Biotin, Fc-specific), assay development kits, and precision capillary consumables. Key technology platforms include nanoDSF, Dynamic Light Scattering (DLS), Static Light Scattering (SLS), Backreflection, Spectral Shift, MicroScale Thermophoresis (MST), and Temperature-Related Intensity Change (TRIC), enabling measurements from protein stability to molecular interaction analysis. Recent expansion includes the acquisition of Envue Technologies and its Nanofluidic Scattering Microscopy (NSM) technology for single-molecule, label-free analysis.

Differentiator

Problem solved

Functional benefit

Products and services

  • Prometheus Panta Multi-parameter protein stability instrument combining nanoDSF, DLS, SLS, and Backreflection to measure thermal unfolding and colloidal stability of proteins in a single run, used by biopharma and academic researchers for biologics characterization.
  • Dianthus Affinity screening instrument enabling in-solution binding analysis for tough drug-discovery targets via Spectral Shift technology, supporting confident candidate decisions in targeted protein degradation and biologics programs.
  • Dianthus uHTS High-throughput screening version of the Dianthus platform designed to accelerate screening and discovery workflows with faster turnaround for affinity measurements.
  • Monolith Affinity measurement instrument based on MicroScale Thermophoresis (MST), requiring minimal sample while delivering molecular interaction insights for protein research and drug discovery.
  • Monolith Omni Affinity measurement instrument variant of the Monolith platform offering more answers with less complexity in molecular interaction analysis.
  • Andromeda Protein stability characterization instrument designed for analysis of crude lysates, enabling early-stage decision-making without purification requirements for biologics and protein research workflows.
  • Tycho NT.6 Rapid protein quality check instrument using capillary-based technology suitable for virtually all buffers and sample concentrations, used as a fast triage tool before deeper characterization.
  • Protein Labeling Kit RED-NHS 2nd Generation Amine-reactive NHS-ester labeling kit for affinity studies that delivers higher binding amplitudes and improved signal-to-noise ratios for proteins larger than 5 kDa.
  • Protein Labeling Kit RED-MALEIMIDE 2nd Generation Cysteine-reactive labeling kit enabling site-specific labeling and affinity studies with improved data quality for previously challenging targets.
  • His-Tag Labeling Kit RED-tris-NTA 2nd Generation Site-specific, purification-free labeling kit for His-tagged proteins and peptides, compatible with both purified and crude samples.
  • Andromeda His-Tag Labeling Kit Site-specific labeling kit for polyhistidine-tagged proteins in crude lysate, completing labeling in 30 minutes without dye removal required.
  • Biotinylated Target Labeling Kit Site-directed labeling kit for biotin-tagged proteins and peptides with a 15-minute labeling protocol and no dye removal required.
  • Human Fc Labeling Kit Site-specific labeling kit for human Fc antibody regions with a purification-free workflow optimized for Spectral Shift technology.
  • Buffer Exploration Kit 96 deep-well plate containing various buffer conditions for MST, TRIC, protein stability, purification, and storage assay development.
  • Monolith NT.Automated Capillary Chips High-precision glass capillaries for automated Monolith instruments, providing 384 data points per package for high-throughput affinity measurements.
  • Prometheus NT.Plex Capillary Chips nanoDSF-grade capillary chips for use with Prometheus Panta instruments, available in standard and high-sensitivity variants for different protein concentration ranges.
  • Dianthus 384-well Plates Barcoded 384-well plates for TRIC measurements with the Dianthus system, featuring hard-sided black/black construction with clear bottom and 18-25 µL working volume.

Quantifiable outcome

  • From data to decisions - enabling breakthrough biophysical characterization

Companies that use NanoTemper Technologies

Customer profile

Named customers2 records

Segments4 records

Ideal customer profiles3 records

NanoTemper Technologies technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature7 records

NanoTemper Technologies partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Envue TechnologiescoreStrategic or Co-development Partner · 5 November 2025Acquisition of Swedish startup Envue Technologies specializing in Nanofluidic Scattering Microscopy (NSM). This acquisition enhances NanoTemper's biophysical analysis portfolio and supports early-stage biopharmaceutical research, particularly in nucleic acid and protein therapeutic discovery. Integration of NSM technology with spectral shift analysis expands capabilities.

Scale indicators5 records

Recent moves7 records

Expansion highlights5 records

NanoTemper Technologies competitors and assessment

Company assessment

Broad incumbents

  • Cytiva (formerly GE Healthcare Life Sciences): Broad incumbent with Biacore SPR systems that compete directly with Monolith/Dianthus for affinity and kinetic analysis, plus a large bioprocessing and protein purification portfolio that gives Cytiva significant cross-sell leverage against NanoTemper in biopharma accounts.
  • Bruker: Broad incumbent in analytical instruments with mass spectrometry and biophysical tools that overlap with NanoTemper's protein characterization workflows in structural biology and biologics development.
  • Thermo Fisher Scientific: Broad incumbent offering a full analytical and life-sciences instrument stack, including chromatography, mass spectrometry, and protein interaction tools that compete with NanoTemper's biophysical portfolio as part of larger procurement deals.
  • Waters Corporation: Broad incumbent in analytical instruments and chromatography with growing presence in biologics characterization, competing with NanoTemper at the workflow level for biopharma QC and characterization budgets.
  • Sartorius (incl. FortéBio): Broad incumbent through FortéBio's BLI (Bio-Layer Interferometry) Octet platform, which competes with MST and TRIC for label-free protein interaction and quantitation, and brings significant scale and bioprocess bundling power.

Direct peers

  • Malvern Panalytical: Direct competitor in biophysical characterization, offering Zetasizer (DLS), light scattering, and protein characterization tools that overlap directly with NanoTemper's Prometheus and DLS portfolio for biologics development and formulation.
  • Wyatt Technology: Closest direct peer in light-scattering-based protein characterization, with DLS/SLS/MALS instruments and microcalorimetry used for the same biologics, formulation, and biophysics workflows that NanoTemper's Prometheus Panta platform addresses.
  • Creoptix: Direct competitor in label-free affinity measurement, offering the WAVEsystem (a grating-coupled interferometry platform) that competes head-to-head with NanoTemper's Monolith/MST and Dianthus/TRIC instruments for kinetic and affinity analysis.
  • Dynamic Biosensors: Direct competitor using switchSENSE technology for real-time kinetic and affinity measurements on DNA nanolevers, overlapping with Monolith/MST and Dianthus use cases in protein interaction and drug discovery characterization.

Emerging players

  • Unchained Labs: Emerging player in biologics characterization tools (including Uncle for stability and Hunky for stability/aggregation), competing with portions of NanoTemper's Prometheus and Tycho offerings in the biologics formulation and developability workflow.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

NanoTemper Technologies social profiles

Digital presence

NanoTemper Technologies financial estimates

Financial estimate

Revenue estimate

Valuation estimate

NanoTemper Technologies leadership team

Management profile

Number of profiles

Profiles8 records

NanoTemper Technologies subsidiaries and ownership

Company hierarchy

Subsidiaries7 records

NanoTemper Technologies funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

NanoTemper Technologies M&A and investment

M&A and investment

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NanoTemper Technologies

What does NanoTemper Technologies do?

NanoTemper Technologies develops and manufactures biophysical characterization instruments, proprietary consumables, and analysis software that enable drug discovery and protein research scientists to measure protein stability, aggregation, and molecular binding interactions. The core product lines — Prometheus Panta, Dianthus / Dianthus uHTS, Monolith / Monolith Omni, Andromeda, and Tycho NT.6 — are supported by labeling kits, capillary chips, and plates sold via the company's online shop and direct sales channels.

Is NanoTemper Technologies a public or private company?

NanoTemper Technologies is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was NanoTemper Technologies founded?

NanoTemper Technologies was founded in 2008. It employs 101 to 250 people.

Where is NanoTemper Technologies based?

NanoTemper Technologies is headquartered in Munich, Germany, in the Europe region.

How does NanoTemper Technologies make money?

Four revenue lines are on record. Instruments and Hardware is the primary driver. The others are consumables and Reagents, software Licenses and service and Maintenance.

Who are NanoTemper Technologies's main competitors?

Broad incumbents on record are Cytiva (formerly GE Healthcare Life Sciences), Bruker, Thermo Fisher Scientific, Waters Corporation and Sartorius (incl. FortéBio). Direct peers are Malvern Panalytical, Wyatt Technology, Creoptix and Dynamic Biosensors. Unchained Labs is listed as an emerging player.

Does NanoTemper Technologies have an API?

No public API is recorded for NanoTemper Technologies.

What industry is NanoTemper Technologies in?

NanoTemper Technologies's product category is Biophysical Characterization Instruments. Its primary akta.pro industry code is HLAGADAK, Material Characterization & Spectroscopy (NMR/FTIR/MS), with a secondary code of HLAGAHAI, Solid-State Chemistry & Preformulation (Polymorph/Crystallization). Its NAICS code is 334516 and its SIC code is 3826.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
BioProcess InternationalBiotech firms shake up 2026 with executive appointmentsSeveral biotechnology firms announced significant executive appointments to strengthen their leadership for the upcoming year. NanoSyrinx appointed Thomas Farrell as CEO, Novotech named Anand Tharmaratnam as its new CEO, and NanoTemper Technologies formed a new executive leadership team led by co-founder Stefan Duhr. These changes are aimed at advancing their respective strategic objectives and expanding market capabilities in the biotechnology sector.The Mass Spectrometry Web PortalNanoTemper Technologies GmbH. (1/8/26). "Press Release: NanoTemper Introduces New Executive Leadership Team to Advance Biophysical Innovation".NanoTemper introduced a new executive leadership team led by CEO Stefan Duhr, including roles for commercial, financial, HR, scientific, and technology leadership. The team brings experience in drug discovery and bioprocessing, aiming to advance biophysical characterization solutions for drug discovery.news.cision.comProposed New Board Members in Bio-WorksBio-Works' Nomination Committee proposed two new board members, Eva Lindskog and Andrea Ballagi, for the 2026 Annual General Meeting, plus re-election of four existing members and Peter Ehrenheim as chairman. Lindskog brings bioprocessing expertise from NanoTemper, while Ballagi brings oncology market development experience from Olink.MmustMMUST Set to Strengthen Biophysical Research Capacity With Acquisition of Prometheus NT.48 Protein Analysis EquipmentMasinde Muliro University of Science and Technology (MMUST) received a Prometheus NT.48 protein analysis instrument donated by NanoTemper Technologies to enhance its biophysical research capabilities. The equipment was officially handed over on January 16, 2025, as part of a collaborative initiative led by Dr. Philip Amuyunzu Mang’are involving researchers from Spain and Germany. This acquisition is intended to strengthen evidence-based research, postgraduate training, and the university's global competitiveness in biomedical sciences.The Mass Spectrometry Web PortalNanoTemper Technologies GmbH. (11/5/25). "Press Release: NanoTemper Strengthens Biopharma Discovery Portfolio with Acquisition of Envue Technologies and Launch of Dianthus a". Munich & Gothenburg.NanoTemper Technologies GmbH has acquired Envue Technologies, a Swedish startup specializing in Nanofluidic Scattering Microscopy (NSM), and simultaneously launched Dianthus™ a application to strengthen its biopharma discovery portfolio. The acquisition enables single-molecule, label-free analysis capabilities, while Dianthus™ a adds Optical Unfolding and Slow Kinetics features to NanoTemper's existing Spectral Shift technology. These strategic milestones aim to help researchers make faster, more confident decisions in early-stage drug discovery across nucleic acid and protein modalities.Pulse 2.0NanoTemper Expands Drug Discovery Capabilities With Envue Acquisition And Launch Of Dianthus αNanoTemper Technologies has acquired Envue Technologies, a Swedish company specializing in Nanofluidic Scattering Microscopy, and simultaneously launched its new Dianthus α application to expand its biophysical analysis capabilities for early-stage biopharmaceutical research. The acquisition integrates Envue's label-free, single-molecule NSM technology with NanoTemper's existing Spectral Shift and TRIC technologies, enabling researchers to better characterize nucleic acid and protein therapeutics and assess hard-to-drug targets. NanoTemper will continue collaborating with industry and academic partners to streamline the process from data collection to therapeutic candidate selection.PR NewswireNanoTemper Strengthens Biopharma Discovery Portfolio with Acquisition of Envue Technologies and Launch of Dianthus™ αNanoTemper Technologies announced the acquisition of Envue Technologies and the launch of its Dianthus™ α application, expanding its biophysical analysis tools for drug discovery. The acquisition brings in Nanofluidic Scattering Microscopy (NSM) technology for label-free, single-molecule analysis, aiming to improve early-stage research in therapeutics.BioSpaceNanoTemper Technologies Announces Monolith X With Breakthrough Spectral Shift Technology, Enabling Binding Affinity Measurements Where Other Methods FailNanoTemper Technologies introduced Monolith X, adding Spectral Shift technology to its Monolith product line. The device combines Spectral Shift and MST to measure binding interactions, addressing challenges with unstable samples and buffer requirements. The company states it aims to help scientists overcome binding affinity measurement difficulties.BioSpaceNanoTemper Technologies Arms Gene Therapy Scientists With Static Light Scattering to Sharpen Their Tool Kit for Development of AAVsNanoTemper Technologies added Static Light Scattering (SLS) to its Prometheus Panta instrument, enabling characterization of AAV vectors with minimal sample. The company stated this addresses gene therapy researchers' limited AAV sample and need for fewer measurements.Business Wire BlogNanoTemper Technologies Launches DLS Capability With Prometheus Panta, Bringing High-Resolution, Domain-Specific Stability Characterization to BiologicsNanoTemper Technologies launched Prometheus Panta, a multi-parameter stability characterization instrument combining DLS, nanoDSF, and backreflection. The system enables correlation of particle sizing, thermal unfolding, and aggregation across a thermal ramp, aiding biologics formulation and developability assessments.